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Polyunsaturated fatty acids (PUFAs) are important constituents of the diet and health beneﬁts of omega-
3/n3 PUFAs, especially eicosapentaenoic acid (EPA, 20:5 n3) and docosahexaenoic acid (DHA, 22:6
n3) have been well documented in relation to several diseases. Increasing evidence suggests that n3
PUFAs may have anticancer activity and improve the effect of conventional cancer therapy. The me-
chanisms behind these effects are still unclear and need to be elucidated.
We have examined the DHA-induced stress response in two human colon cancer cell lines, SW620
and Caco-2. SW620 cells are growth-inhibited at early time points by DHA, while the growth of Caco-2
cells almost remains unaffected by the same treatment. Gene expression analysis of SW620 cells treated
with DHA revealed changes at early time points; transcripts involved in oxidative stress and autophagy
were among the ﬁrst to be differentially expressed. We ﬁnd that oxidative stress is induced in both cell
lines, although at different time points and to different extent. DHA induced nuclear translocation of the
oxidative stress sensor NFE2L2 in both cell lines, indicating an induction of an anti-oxidative response.
However, vitamin E did not counteract ROS-production or the translocation of NFE2L2 to the nucleus.
Neither vitamin E nor the antioxidants butylated hydoxyanisole (BHA) and butylated hydoxytoluene
(BHT) did affect the growth inhibition in SW620 cells after DHA-treatment. Also, siRNA-mediated down-
regulation of NFE2L2 did not sensitize SW620 and Caco-2 cells to DHA. These results indicate that oxi-
dative stress response is not the cause of DHA-induced cytotoxicity in SW620 cells.
Using biochemical and imaging based functional assays, we found a low basal level of autophagy and
no increase in autophagic ﬂux after adding DHA to the SW620 cells. However, Caco-2 cells displayed a
higher level of autophagy, both in the absence and presence of DHA. Inhibition of autophagy by siRNA
mediated knock down of ATG5 and ATG7 sensitized both SW620 and Caco-2 cells to DHA. Stimulation of
autophagy by rapamycin in SW620 and Caco-2 cells resulted in decreased DHA-sensitivity and inhibition
of autophagy in Caco-2 cells by chloroquine resulted in increased DHA-sensitivity.
These results suggest that autophagy is important for the DHA sensitivity of colon cancer cells and
imply possible therapeutic effects of this fatty acid against cancer cells with low autophagy.
& 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Several epidemiological studies have pointed to a positive
correlation between dietary ﬁsh intake and the reduced risk of
developing age related disorders such as circulatory disturbances,
neurodegenerative diseases, and different types of cancer [1–3].
The disease preventive effects of increased ﬁsh intake have been
associated with the content of omega-3 (n–3) polyunsaturated
fatty acids (PUFAs) present in marine species [4]. Case-control
studies have suggested an inverse correlation between dietary ﬁsh
intake and colorectal cancer [5,6]. n3 PUFAs have been shown to
inhibit growth of human cancer cells in culture and when grafted
in mice [7,8]. Several mechanisms have been proposed to explain
the anticancer activity mediated by n3 PUFAs like increased
oxidative stress, lipid peroxidation, modulation of cyclooxygenase
activity and changes in membrane phospholipid composition and
receptor function [9–11]. However, why some cancer cells die and
others survive when exposed to n3 PUFAs is still poorly deﬁned.
We have previously shown that docosahexaenoic acid (DHA,
22:6n3) induces endoplasmic reticulum (ER) stress, unfolded
protein response (UPR) and growth arrest in several human cancer
cell lines [12–14]. Increased protein levels of PKR-like ER kinase
(PERK)-mediated phosphorylation of eukaryotic translation in-
itiation factor 2alpha (eIF2α), indicative of ER stress, were found at
early time points [14]. The main functions of the ER are protein
synthesis and folding, maintenance of calcium homeostasis and
lipid synthesis. Interference with any of these processes may lead
to ER-stress and activation of UPR in order to restore cellular
homeostasis. The activation of UPR is followed by attenuation of
protein translation and activating transcription factor 4 (ATF4)
mediated up-regulation of genes to ensure cell survival or to
mediate cell death when stress is too severe.
Recently, it has become clear that induction of ER stress as well
as several other forms of cellular stress like nutrient deprivation,
reactive oxygen species (ROS), DNA damage, protein aggregates
and damaged organelles may lead to the induction of autophagy as
reviewed in [15]. Macroautophagy (hereafter referred to as au-
tophagy) is a catabolic process that removes damaged cellular
components to maintain cellular integrity and stability [16]. Dur-
ing the autophagic process, cytoplasmic proteins and organelles
are sequestered by a growing double membrane that forms an
autophagosomal vesicle, and the content is degraded after fusion
with a lysosome. A basal activity of autophagy is needed to
maintain normal cellular homeostasis, and the level of activity
may be increased in response to different kinds of stresses [17,18].
Dysregulation of this process is linked to different conditions like
neurodegeneration, aging, cancer, and infectious-, cardiovascular-
and metabolic diseases. In cancer, autophagy has dual roles by
acting both as a tumor suppressor preventing initiation of tu-
morigenesis, but also by assisting cancer cells in coping with
stressful conditions thereby promoting cancer cell growth [19].
Autophagy is a highly evolutionary conserved process that is
regulated by autophagy-related genes (ATGs) [20]. The ATG 1/Unc-
51-like kinase 1/2 (ULK1/2 kinase) is considered a principal reg-
ulator of autophagy [21]. The ULK1/2 kinase activity and its ability
to stimulate autophagy is negatively regulated by the mammalian
target of rapamycin complex 1, mTORC1 [22]. When activated,
mTOR inhibits autophagy by phosphorylation of ULK1 [23]. The
tumor suppressors 5′ AMP-activated protein kinase (AMPK),
phosphatase and tensin homolog (PTEN), liver kinase B1 (LKB1)
and tuberous sclerosis 1/2 (TSC1/2) positively regulate autophagy
both by inhibiting mTOR and by activating the ULK1/2 activity
directly [21]. ATF4 also regulates mTOR activity negatively via
transcriptional up-regulation of DNA-damage-inducible transcript
4 (REDD1) [24]. During ER stress, the PERK-eIF2α-ATF4 branch of
UPR is required for increased expression of REDD1. ER stress mayalso lead to the production of ROS and vice versa; it is however not
clear whether oxidative stress is involved in autophagy mediated
by ER stress.
The redox-sensitive transcription factor nuclear factor ery-
throid-2-related factor-2 (NFE2L2/Nrf-2) regulates the expression
of genes involved in the endogenous antioxidant response [25]. In
unstressed conditions, NFE2L2 is distributed in the cytoplasm in
association with kelch like-ECH-associated protein 1 (KEAP1), a
protein essential for the regulation of NFE2L2 activity through
degradation via the ubiquitin–proteasome system [26]. When
stress is induced, NFE2L2 is phosphorylated and dissociates from
KEAP1 and translocates to the nucleus where it activates target
genes involved in the antioxidant defense or phase II detoxiﬁca-
tion through interaction with the antioxidant response element
(ARE) [27]. NFE2L2 has also been shown to be a direct substrate for
the PERK kinase activity. Upon ER stress, PERK phosphorylates
NFE2L2 to promote dissociation from KEAP1 and translocation to
the nucleus [28]. The sequestosome 1 protein (SQSTM1/p62) is a
scaffold protein involved in clearance of ubiquitinated protein
aggregates and organelles through selective autophagy [29,30].
The promoter of SQSTM1 contains an ARE-element and tran-
scription of SQSTM1 is thus regulated by NFE2L2 [31]. SQSTM1 has
also been shown to interact with KEAP1 at the NFE2L2 binding
site, leading to NFE2L2 release and translocation to the nucleus
thereby contributing to a positive feedback regulation of self-
transcription [32].
The signaling pathways of ER stress, oxidative stress and autop-
hagy are complex and seem to be interrelated. We have previously
shown by gene expression proﬁling that treating the human colon
cancer cell line SW620 with the n3 PUFA DHA increases the level
of transcripts involved in ER stress and NFE2L2 target transcripts like
heme oxygenase 1 (HMOX1), glutamate-cysteine ligase modiﬁer
(GCLM), thioredoxin reductase 1 (TXNRD1) and SQSTM1 [14]. In this
study we explore whether oxidative stress and/or autophagy could
be involved in modulating the cytotoxic effect of DHA in human
colon cancer cell lines.
We here report that oxidative stress- and autophagy-related
transcripts are among the primary response genes to DHA in
SW620 colon cancer cells. Vitamin E did not counteract DHA-in-
duced ROS, did not interfere with nuclear translocation of NFE2L2
and did not restore cell growth in SW620 cells. SiRNA-mediated
down-regulation of NFE2L2 did not sensitize Caco-2 cells to DHA.
These results indicate that oxidative stress is not the cause of DHA-
induced cytotoxicity in SW620 cells. Even though several autop-
hagy related genes are induced in the sensitive SW620 cells in
response to DHA, no evident activation of the autophagy process
could be observed in these cancer cells. Inhibition of autophagy by
siRNA mediated knock down of ATG5 and ATG7 sensitized both
SW620 and Caco-2 cells to DHA while stimulating autophagy in
both cell lines by inhibiting mTOR resulted in decreased DHA
sensitivity.
Our results indicate that the basal level of autophagy is im-
portant for surviving the cellular stress induced by DHA and
suggest that colon cancer cells with low basal autophagy are more
sensitive to stress and may be targeted by DHA.2. Materials and methods
2.1. Cell cultures and reagents
SW620 and Caco-2 cells were obtained from American Type
Culture Collection (ATCC) (Rockville, MD). SW620 cells were cul-
tured in Leibovitz’s L-15 medium (#BE-12-700, Lonza, Basel,
Switzerland), supplemented with L-glutamine (#17-605E, Lonza,
2 mM), Fetal Bovine Serum (FBS, 10270, Gibco, 10%) and
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cultured in Eagle medium (#M5650, Sigma-Aldrich) supple-
mented with L-glutamine (#17-605E/ Lonza, 2 mM), Sodium pyr-
uvate (#P5280, Sigma-Aldrich, 1%), Gentamicin (0.05 mg/ml), and
FBS (20%). Cells were maintained in a humidiﬁed atmosphere of
5% CO2; 95% air at 37 °C.
4,7,10,13,16,19-docosahexaenoic acid (DHA) and 9-octadecanoic
acid (OA) were obtained from Cayman Chemical (Ann Arbor, MI) as
solutions in ethanol. Vitamin E (7-α-tocopherol, T3251), Buty-
lated hydroxyanisole (BHA, B1253), Butylated hydroxytoluene
(BHT, B1378), Rapamycin (R8781), Baﬁlomycin A1 (BafA1, B1793),
Chloroquine (Chl, C6628) and Hanks’ Balanced Salt Solution (HBSS,
#H8264) were obtained from Sigma-Aldrich (St. Louis, MO).
The following primary antibodies were used: Speciﬁc to
SQSTM1 (#GP-62-C, Progen Biotechnik); NFE2L2 (#sc-13032,
H-300, Santa Cruz Biotechnology, Inc. and #12721, D1Z9C, Cell
Signaling Technologies); LC3B-II (#3868, D11, Cell Signaling
Technologies); HMOX1 (#ADI-OSA-110, Stressgen); BAG3
(#ab47124, Abcam); HSPA1A (#SPA-810, Stressgen), ACTB
(#ab6276, AC-15, Abcam); TUBB (#ab6046, Abcam); COX IV
(#ab33985, Abcam and #926-42214, Li-cor Biotechnology, Inc),
KEAP1 (#sc-15246, E20, Santa Cruz Biotechnology, Inc), TRIB3
(#HPA015272, Sigma Aldrich). All secondary antibodies were from
Molecular Probes (Alexa conjungates) or Li-Cor Biotechnology (NIR
dye conjungates).
2.2. Fatty acid supplementation and survival assays
Stock solutions of fatty acids in ethanol were stored at 20 °C
and further diluted in complete growth medium with FBS before
experiments, such that the ﬁnal concentration of ethanol was
o0.025% (v/v). DHA/OA/BafA1-treatments were initiated 24 h
after cell seeding. MTT-assay was performed as previously de-
scribed [12].
Cell proliferation was also monitored in real time using the
xCELLigence RTCA DP instrument (ACEA Biosciences Inc.) accord-
ing to the supplier’s recommendations. Where indicated, the cells
were pretreated with 50 nM rapamycin for 30 min before adding
fresh medium containing vehicle or DHA. For inhibition of au-
tophagy, chloroquine (10 mM) was added alone or in combination
with DHA (70 mM). For starvation, total L-15 medium was diluted
with 50% HBSS.
2.3. Gene expression proﬁling
SW620 cells were treated with vehicle (ethanol) or 70 mM DHA
for 30 min, 1, 3, 6, 24 and 48 h before RNA isolation. Expression
proﬁling was performed in triplicates at all time points, except for
1 h, where one control array was excluded. The statistical analysis
was based on summary expression measures using the raw data
(CEL) ﬁles performed by the robust multiarray average method as
previously described [14,33]. The statistical analysis was per-
formed in R (http://www.r-project.org), using packages Limma and
Affy from Bioconductor. Differentially expressed genes were se-
lected based on a threshold of 0.05 on the adjusted P values. All
data have been submitted to ArrayExpress with the accession
numbers E-MEXP-2010 (30 min, 1, 3, 6 h) and E-MEXP-1014 (12,
24, 48 h).
2.4. siRNA mediated knock down and transient transfection
For NFE2L2 down regulation, Caco-2 cells and SW620 cells
were transfected using 10–20 nM and 50 nM siRNA (ﬁnal con-
centrations), respectively and DharmaFECT transfection reagent 1
(Dharmacon) diluted in Optimem 1 Reduced Serum Medium
(#31985-070, Gibco Life Technologies). Following 24 h, the cellswere collected by trypsination and seeded for real-time cell
monitoring, cell counting and immunoblot analysis. The following
siRNA oligonucleotides were obtained from Dharmacon; non-tar-
geting siRNA (D-001210-01); NFE2L2 siRNA (D-003755-02, target
sequence: 5′-CCAAAGAGCAGUUCAAUGA); ATG5 (L-004374-00)
and ATG7 (L-020112-00), SQSTM1 (J-010230-06-0020, target se-
quence 5′-GCAUUGAAGUUGAUAUCGA) and HMOX1 (D_006372-
05-0050, target sequence: 5′-GGCAGAGGGUGAUAGAAGA). Allstars
negative control siRNA (#1027280) and Allstar HS Cell Death
Control siRNA (#1027298) were obtained from Qiagen.
The double tag mCherry-EGFP [30] was transfected into the
cells using X-treme GENE HP DNA Transfection Reagent (Roche)
following the supplier’s recommendations. After transfection, cells
were seeded in wells with cover-glass bottom, left for 24 h before
adding vehicle or DHA for 16 h. Cells were ﬁxated using 4% para-
formaldehyde in PBS (pH 7.2) for 10 min and stored in PBS until
confocal microscope imaging. The number of punctuated green
and red structures per cell was determined in more than 100 cells
per condition per experiment.
2.5. Detection of ROS and lipid peroxidation
ROS production was determined using the Image-iT ™ LIVE
Green Reactive Oxygen Species Detection Kit (DCF, Molecular
Probes) and a BD FACS Canto ﬂow cytometer (BD Biosciences) in
SW620 and Caco-2 cells. As a positive control, 100 mM tert-butyl
hydroperoxide (TBHP) was added 80 min before intracellular ROS
was determined. Mitochondrial superoxide production was de-
termined using 5 mM MitoSOXTM Red (Molecular Probes) mi-
tochondrial superoxide indicator.
Lipid peroxidation in Caco-2 cells was measured as the sec-
ondary lipid peroxidation product malondialdehyde (MDA) using
the OxiSelectTM TBARS Assay Kit (Cell Biolabs, INC). Caco-2 cells
were treated with vehicle, DHA (70 mM), vitamin E (50 mM) or co-
treated with DHA (70 mM) and vitamin E (50 mM) for 72 h before
scraping in ice cold PBS and frozen in aliquots of 20106 cells/ml.
MDA reacts with thiobarbituric acid (TBA) resulting in thiobarbi-
turic acid reactive substances (TBARS) that are measured
colorimetrically.
2.6. Cellular localization of autophagy biomarkers and NFE2L2
Subcellular localization of SQSTM1, NFE2L2 and LC3B was de-
termined by immunostaining and visualization by ﬂuorescently la-
beled secondary antibodies. Immunostaining was imaged by an
Axiovert200 microscope equipped with a 631.2W objective and
the confocal module LSM510 META (Carl Zeiss). Images were pro-
cessed using the LSM software (Carl Zeiss) and mounted using
Canvas 11 (ACD Systems). Images are representative of more than
200 randomly selected cells in each condition and of two or more
independent experiments. Cytoplasmic structures enriched for LC3
were quantiﬁed by using the histogram function in the LSM soft-
ware. All images were taken with the same settings. Pixels positive
for LC3B with an intensity of more than 100 RLU were counted and
divided by the number of cells in the image (more than 100 cells per
condition).
2.7. Autophagy determined by ﬂow cytometry
Autophagic structures were determined using the CytoID au-
tophagy detection kit following the suppliers’ instructions (Enzo
Life Sciences). Brieﬂy, the cells were detached by trypsination and
stained in a solution with Cyto-ID Detection Reagent covered from
light for 30 min at room temperature with gentle rotation, and the
ﬂuorescent intensity per cell was determined using a ﬂow
cytometer.
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Cells, transfected or non-transfected, untreated or treated with
DHA and/or 100 nM BafA1, were harvested by trypsinization or
scraped in ice cold PBS. Cells were lysed in either a buffer containing
1% NP40, 0.25% Triton-X100, 50 mM Tris–HCl (pH 8.0), 150 mM
NaCl, 1 mM EDTA pH 8, Complete
s
protease inhibitor (PI, Roche),
and phosphatase inhibitor cocktail I and III (Sigma-Aldrich), or an
urea buffer containing 8 M Urea, 0.5% (v/v) Triton X-100, 100 mM
DTT, PI, and phosphatase inhibitor cocktail I and III. Total protein
concentration in the lysates was determined by Bio-Rad protein
assay (Bio-Rad). Bound antibodies were imaged by near infrared
ﬂuorescence using appropriate ﬂuorescent dye labeled secondary
antibodies and an Odyssey NIR scanner (Li-Cor Biosciences). Images
were processed using the Li-Cor Odyssey software and mounted
using the Canvas 11 software (ACD Systems).3. Results
3.1. DHA induces changes in expression of genes involved in oxida-
tive stress, protein folding and autophagy at early time points
The effect of DHA on cell growth/cell index of the colon cancer
cell lines SW620 and Caco-2 was determined by MTT assay and
real time analysis (xCELLigence System), respectively (Fig. 1). The
effect on cell growth/cell index measured by both systems corre-
sponded well. We found that DHA reduced growth of SW620 cells
in a time- and concentration-dependent manner, as measured by
the MTT assay. Cell viability started to decline after approximately
24 h supplementation with DHA (70 mM) in SW620 cells; a 30%
and 50% reduction in cell viability could be observed after 48 and
72 h, respectively. The cell growth/cell index of Caco-2 cells were
almost unaffected by the same treatment. Supplementation of
SW620 cells with the monounsaturated fatty acid oleic acid (OA)Fig. 1. Effect of DHA and OA on cell growth/cell index of the human colon cancer cell line
was performed in triplicate and the values represent the mean7SD. Cell index was m
measurements and the normalized cell index curves are one representative out of two(18:1, n9) did not result in any change in cell index relative to
control cells. The relative differences in response to DHA were
veriﬁed by conventional cell counting (data not shown). The rapid
growth retardation after supplementation with DHA in SW620
cells suggest that relevant gene expression changes could occur
very early.
We have previously performed gene expression analysis of
SW620 cells after treatment with DHA (70 mM) or vehicle for 0.5, 1,
3, 6, 12, 24 and 48 h. No signiﬁcant changes in gene expression were
observed until 3 h after DHA supplementation [33]. At 3 h, 21
transcripts were found differentially expressed; 17 of these were up-
regulated, whereas 5 were down-regulated (data not shown).
Among the earliest DHA-responsive transcripts was SQSTM1 (Ta-
ble 1). The autophagy cargo receptor SQSTM1 physically links mis-
folded, ubiquitinated proteins to ATG8-family members located on
the forming autophagosomal membrane [29,30]. At 3 h, we also
identiﬁed increased mRNA levels of the Bcl2-associated athanogene
3 (BAG3), as well as the chaperones Heat shock protein 40 (Hsp40)
and Hsp70, the oxidative stress response gene HMOX1 and the ER
stress response gene REDD1. After 6 h with DHA, 16 of the 21
transcripts were still differentially expressed. Moreover, an increased
number of transcripts were differentially expressed at 6 h; 859 were
up-regulated and 587 were down-regulated. The immediate acti-
vation of SQSTM1 and BAG3 may suggest induction of autophagy as
a primary transcriptional response to DHA. In line with this, several
ATG transcripts, including microtubule-associated protein 1 light
chain 3 beta (LC3B) and its homologs GABA(A) receptor-associated
protein like 1 (GABARAP-L1 and -L2), ATG14, as well as the autop-
hagy regulators ULK1, sestrin 2 (SESN2) and Tribbles homolog 3
(TRIB3) were found to be signiﬁcantly up-regulated (po0.05) after
6 h DHA-treatment. Previous obtained gene expression data of
SW620 cells treated with DHA for longer periods of time (12, 24 and
48 h) [14] also revealed increased mRNA levels of ATG12, BCL2/
adenovirus E1B 19 kDa interacting protein 3-like (Bnip3L/Nix), and
phosphoinositide-3-kinase class 3 (Vps34). For complete lists ofs SW620 and Caco-2. Cell viability was assayed using the MTT assay. The experiment
easured real-time by the xCELLigence system. The cell index is based on triplicate
parallel experiments.
Table 1
Differentially expressed transcripts involved in autophagy and oxidative stress response in SW620 cells after treatment with DHA (70 mM) at time points indicated.
Gene symbol Affymetrix ID Refseq NCBI ID Transcript name Fold change
3 h 6 h 12 h 24 h 48 h
ATG1/ULK1 209333_at NM_003565 Unc-51-like kinase 1 (C. elegans) NC 2.1 2.3 2.3 NC
ATG1/ULK1 238042_at AW_134485 Unc-51-like kinase 1 (C. elegans) NC 1.9 NA NA NA
ATG12 213026_at NM_004707 Autophagy related 12 homolog (S. cerevisiae) NC NC 1.4 NC NC
NR_033362
NR_033363
ATG14 204568_at NM_014924 Autophagy related 14 homolog (S. cerevisiae) NC 1.3 NA NA NA
BAG3 217911_s_at NM_004281 BCL2-associated athanogene 3a 1.9 3.5 9.9 5.4 NC
BNIP3L/NIX 221479_s_at NM_004331 BCL2/adenovirus E1B 19 kDa interacting protein 3-like NC NC 1.5 1.8 NC
DNAJB1 200666_s_at NM_006145 DnaJ (Hsp40) homolog, subfamily B, member 1 2.2 4.1 8.0 4.1 NC
DDIT4/REDD1 202887_s_at NM_019058 DNA-damage-inducible transcript 4 5.5 23.1 NA NA NA
FOXO3A 204131_s_at NM_001455 Forkhead box O3 NC NC 1.3 1.4 1.3
NM_201559
HMOX1 203665_at NM_002133 Heme oxygenase (decycling) 1a 3.2 25.6 24.0 10.6 5.7
HSPA1A 200799_at NM_005345 Heat shock 70 kDa protein 1A 4.5 4.1 NA NA NA
HSPA1A/B 200800_s_at NM_005345 Heat shock 70 kDa protein 1A/1Ba 4.4 6.5 17.8 9.8 5.1
202581_at NM_005346 5.4 4.5 9.8 6.5 3.1
GABARAPL1 208868_s_at NM_031412 GABA(A) receptor-associated protein like 1 NC 1.4 NA NA NA
208869_s_at NC 2.0 NA NA NA
GABARAPL1/L3 211458_s_at NM_031412 GABA(A) receptor-associated protein like 1/3 NC 3.1 NA NA NA
NR_028287
GABARAPL2/ATG8 209046_s_at NM_007285 GABA(A) receptor-associated protein-like 2 NC NC NC 1.2 NC
MAP1LC3B 208786_s_at NM_022818 Microtubule-associated protein 1 light chain 3 beta NC 2.4 NC NA NA
MAP1LC3B2 208785_s_at NM_022818 Microtubule-associated protein 1 light chain 3 beta NC 1.9 NC 3.9 2.3
NBR1 201384_s_at NM_005899 Neighbor of BRCA1 gene 1 NC NC NC 1.6 1.4
NM_031858
NM_031862
NFE2L2/NRF2 201146_at NM_001145412 Nuclear factor (erythroid-derived 2)-like 2a NC 1.5 2.0 1.8 NC
NM_001145413
NM_006164
PIK3C3/Vps34 204297_at NM_002647 Phosphoinositide-3-kinase, class 3 NC NC 1.6 1.7 NC
SESN2 223195_s_at NM_031459 Sestrin 2 NC 6.9 NA NA NA
223196_s_at NC 4.2 NA NA NA
SQSTM1/p62 201471_s_at NM_001142298 Sequestosome 1a NC 2.4 6.7 7.3 3.9
213112_s_at NM_001142299 NC 3.0 7.7 6.7 5.0
244804_at NM_003900 2.4 3.4 NA NA NA
TRIB3 218145_at NM_021158 Tribbles homolog 3 (Drosophila)a NC 4.0 7.4 6.5 3.3
1555788_a_at NC 5.25 NA NA NA
NC: No change. NA: Not on array.
a Already published.
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E-MEXP-2010 and E-MEXP-1014.
Results from gene expression analyses were veriﬁed by mea-
suring protein levels of selected targets (SQSTM1, HSPA1A,
HMOX1, TRIB3 and BAG3) in SW620 and Caco-2 cells after DHA-
treatment for 3–48 h (Fig. 2). These analyses demonstrated a cor-
relation between increased mRNA and protein level for these gene
products. The protein level of SQSTM1, HSPA1A, HMOX1 and BAG3increased with time up to 24 h in SW620 cells, while the same
transcripts were much less affected in Caco-2 cells, except for
HMOX1. HMOX1 was found expressed in Caco-2 control cells, and
increased with time up to 12 h, followed by a decrease at 24 and
48 h. HMOX1 was not expressed in SW620 control cells, but was
found expressed after 6 h treatment with DHA. The expression
increased up to 24 h and to a higher extent when compared to
Caco-2 cells, before decreasing at 48 h.
Fig. 2. Western blot analyses of proteins involved in autophagy from total cell extracts of SW620 and Caco-2 cells treated with DHA (70 mM) for indicated time periods (h).
Controls were harvested at all times points, only 24 h control is shown and set to 1. Results were veriﬁed in three independent experiments; one representative blot is
shown. Protein band intensities, normalized against ACTB are displayed and represent mean fold change (SD) of DHA samples relative to control at the indicated time points
for three independent experiments. *Signiﬁcantly different from control at the same time point (student’s t-test, po0.05).
Fig. 3. DHA-induced oxidative stress in SW620 and Caco-2 cells. (A) Changes in ROS levels measured at different time points after DHA treatment (70 mM) by the ﬂuorescent
probe DCF. Data represent mean intensity (7SD) of 10,000 cells per condition and are averaged from more than three independent experiments for the 3 h and 6 h and two
independent experiments for the 24 h time point. *Signiﬁcantly different from control (student’s t-test po0.05). (B) Cellular superoxide production detected by the mi-
tochondrial targeted MitoSOX probe following DHA-treatment (70 μM) or vehicle. The mean MitoSOX intensity in 10,000 cells after 6 h with vehicle was set to 1 for SW620
and Caco-2, and displayed as the mean (7SD) of three independent experiments for the 3 h and 6 h and two independent experiments for the 24 h time point. *Signiﬁcantly
different from control (student’s t-test, po0.05). (C) The level of cellular ROS in 10,000 SW620 cells in triplicate wells per condition was determined using the DCF and
MitoSOX probe by ﬂow cytometry. The cells were treated with only DHA (70 mM, 3 h), preincubated with vitamin E (50 mM, 16 h) before DHA-treatment (70 mM, 3 h) or
pretreated with vitamin E (50 mM, 16 h) and then co-incubated with DHA (70 mM, 3 h). The values represent the mean (7SD) of triplicate measurments in one experiment.
(D) Lipid peroxidation measured as MDA in Caco-2 cells treated with DHA (70 mM) alone or in combination with vitamin E (50 mM) for 72 h. The values represent the
mean7SD of three independent experiments. *Signiﬁcantly different from control, **signiﬁcantly different from control and DHA treated cells (student’s t-test po0.05).
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Fig. 4. DHA-induced activation of NFE2L2 in SW620 and Caco-2 cells. (A) Immunostaining of NFE2L2 in SW620 and Caco-2 cells after DHA (70 μM) or vehicle treatment for
6 h. Nuclear DNA was stained using Draq 5. Scale bar, 10 μm. The percentage of cells with equal or increased staining of NFE2L2 in the nucleus (N) was scored by microscopy
of more than 60 cells for each condition. The results are representative for more than three independent experiments. (B) Immunoblot analysis of total NFE2L2 in total
extracts of SW620 and Caco-2 cells. COX IV was used as a loading control and one representative blot is shown. The blots were quantiﬁed and intensities normalized relative
to loading control. The number under the blot represents mean fold change (SD) of three independent experiments relative to the level in Caco-2 cells which was set to one.
*Signiﬁcantly different from Caco-2 cells (student’s t-test, po0.05). (C) Immunoblot analysis of KEAP1 in total cell extracts of SW620 and Caco-2 cells. The basal level of
KEAP1 relative to tubulin (TUBB) was determined in six independent experiments. *Signiﬁcantly different from SW620 cells (student’s t-test, po0.05).
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of NFE2L2 in the SW620 colon cancer cells
HMOX1 and SQSTM1 have previously been found to be induced by
ROS via activation of the transcription factor NFE2L2 [34]. In the DHA-
sensitive SW620 cells, an increase in ROS was observed already after
3 h of DHA-supplementation and a further increase was observed up
to 24 h (Fig. 3A). Similarly, a clear increase in mitochondrial super-
oxide was detected in response to DHA in SW620 cells (Fig. 3B).
However, the antioxidant vitamin E was not able to counteract DHA-
induced formation of ROS in SW620 cells (Fig. 3C) and had no effect
on cell survival (data not shown). Also, the two antioxidants BHA and
BHT were not able to counteract the growth-inhibitory effect of DHAFig. 5. The level of basal autophagy is low in SW620 compared to Caco-2 colon cancer
BafA1 (200 nM) or a combination of the two. (B) Co-localization between SQSTM1 and
absence of BafA1 (200 nM). The amount of LC3B in autophagy-related punctuated cytop
100 RLU) per cell in more than 100 cells for each condition. The relative differences b
independent experiments. Scale bar: 20 μm. (C) Immunoblotting of LC3B-II and SQSTM
SW620 cells (60 μg total protein per well) and Caco-2 cells (40 μg total protein per wel
independent experiments. *Signiﬁcantly different from 0 h, **Signiﬁcantly different from
SQSTM1 and LC3B-II normalized to the level of ΑCΤΒ in Caco-2 cells relative to the leve
The relative level of p62 and LC3B-II in SW620, respectively, were set to one and the re
levels of LC3B-II in SW620 and Caco-2 cells determined by immunoblotting of total cell e
were normalized to ACTB and related to the 0 h time point in three independent experim
untreated SW620 and Caco-2 cells measured by ﬂow cytometry. Results are mean intens
independent experiments (7SD).in SW620 cells (data not shown). In line with this, vitamin E sup-
plementation did not interfere with DHA-induced nuclear transloca-
tion of NFE2L2 in these cells (data not shown). In contrast, the ROS-
level in Caco-2 cells was elevated only after prolonged treatment
(24 h) of DHAwhen using the superoxide probe and to a much lesser
extent (not signiﬁcant). We therefore measured the level of mal-
ondialdehyde (MDA), a secondary product of lipid peroxidation, in
Caco-2 cells after treatment with DHA alone or in combination with
vitamin E (50 mM) for 72 h (Fig. 3D). A several fold increase in the
MDA level was observed in Caco-2 cells after DHA treatment (70 mM)
for 72 h compared to control cells. Co-treatment with DHA (70 mM)
and vitamin E (50 mM) reduced the level of MDA, but not to the same
level as in control cells (Fig. 3D). We have previously measured thecells. (A) Immunostaining of SQSTM1 and LC3B after 6 h of vehicle, DHA (70 μM),
LC3B in SW620 cells after 6 h of amino acid starvation (HBSS) in the presence or
lasmic structures were quantiﬁed as the number of positive pixels (with more than
etween treated and untreated cell cultures are representative for more than ﬁve
1 in response to DHA observed at different times of BafA1 (100 nM) treatment in
l). ACTB was used as a loading control. Values represent the mean (7SD) of three
0 h and BAFA1 at same time point (student’s t-test, po0.05). (D) The basal level of
l in SW620 cells determined by immunoblotting in four independent experiments.
lative level in Caco-2 determined in extracts made from untreated cells. (E) Protein
xtracts (60 mg) after BafA1 (100 nM) treatment at the indicated time points. Results
ents. (F) Differences in the incorporation of the autophagy related probe CytoID in
ity of 10,000 single cells from triplicate measurements of each cell type from three
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of MDA was increased several fold in SW620 cells after treatment
with DHA (70 mM) and a combinatory treatment with vitamin E
(50 mM) reduced the level of MDA even below that in control cultures.
These results indicate that oxidative stress and lipid peroxidation are
induced by DHA-supplementation in both cell lines, although to dif-
ferent extents and at different time-points.
NFE2L2 is a major regulator of transcription of antioxidant re-
lated genes. We determined the total protein level of NFE2L2 by
immunostaining and found a signiﬁcant higher level of NFE2L2 in
SW620 cells as compared to Caco-2 cells (Fig. 4B). A clear nuclear
translocation of NFE2L2 could be observed in the SW620 cells after
6 h of DHA treatment by confocal imaging (Fig. 4A), at the same time
as we observed accumulation of SQSTM1 protein (Fig. 2A). Even
though ROS could not be detected at early time points in Caco-2
cells, an increased nuclear translocation of NFE2L2 in the Caco-2
cells could be observed after 6 h treatment (Fig. 4A). These results
indicate that the antioxidant defense system is activated in both cell
lines after DHA-supplementation. Also, the level of KEAP1, a nega-
tive regulator of NFE2L2, was found lower in Caco-2 cells compared
to SW620 cells (Fig. 4C). Together, these results demonstrate that
NFE2L2 is translocated to the nucleus in both SW620 and Caco-2
cells, but that the level of ROS induction and growth retardation in
response to DHA is clearly different between the two cell lines.
3.3. Basal autophagy is low and not induced by DHA in SW620 colon
cancer cells
To determine whether DHA could affect autophagy, the au-
tophagy biomarkers LC3B and SQSTM1 were immunostained. The
number of LC3B punctuated structures per cell as well as LC3B–
SQSTM1 double positive structures was found to be clearly higher
in Caco-2 control cells compared to SW620 control cells (Fig. 5A).
By adding baﬁlomycin A1 (BafA1) to inhibit lysosomal degrada-
tion, a clear increase in both the number of punctuated structures
positive for LC3B per cell and the number of SQSTM1–LC3B dou-
ble-positive structures could be observed in both cell lines, al-
though to a much larger extent in Caco-2 cells. These results
suggest a higher basal autophagy in Caco-2 cells as compared to
SW620 cells. DHA treatment did not signiﬁcantly change the
number LC3B punctuated structures in any of the two cell lines,
suggesting that there is no induction of autophagy in response to
DHA supplementation in these colon cancer cell lines. On the other
hand, amino acid starvation of SW620 cells for 3 h caused an in-
crease in the number of pixels positive for LC3B and of cytosolic
structures positive for both LC3B and SQSTM1 (Fig. 5B). Combining
amino acid starvation and inhibition of lysosomal degradation
resulted in a synergistic raise in the number of autophagic struc-
tures positive for both proteins, indicating that autophagy may be
induced in these cells, given the appropriate stimuli.
Autophagic ﬂux was further analyzed by LC3B and SQSTM1
immunoblots of SW620 and Caco-2 cell extracts after treatment
with DHA from 2 to 16 h in the absence or presence of BafA1
(Fig. 5C). Analyzing LC3B-II protein level indicated no increase in
autophagic ﬂux by DHA-supplementation in either cell line
(Fig. 5C). However, the protein level of SQSTM1 was induced in
both cell lines even though the autophagic ﬂux remained un-
affected for the time frame of the experiment (Fig. 2 and Fig. 5C).
Also, the immunoblot analysis revealed that the basal level of
LC3B-II (relative to actin) was approximately 10 fold higher in the
Caco-2 cells compared to the SW620 cells (Fig. 5D). The basal level
of SQSTM1 was found equal. The higher basal level of LC3B-II was
not due to a blockade of autophagy in the Caco-2 cells, because the
level was increased even further after inhibiting lysosomal activity
(Fig. 5E). Autophagy was also quantiﬁed as incorporation of the
ﬂuorescent autophagy related probe Cyto-ID detected by ﬂowcytometry. These analyses revealed that Caco-2 cells displayed a
more than 8-fold higher intensity per cell compared to the SW620
cells (Fig. 5F). Consistent with the immunoblot analyses, DHA did
not cause any signiﬁcant increase in CytoID incorporation in
SW620 or Caco-2 (data not shown).
We have previously generated a double tag construct com-
posed of mCherry fused to EGFP [30]. This fusion protein is pH
sensitive, since mCherry is very pH-stable whereas EGFP is labile
and loses its ﬂuorescence in the acidic lysosomes. The double tag
protein showed very different pattern distribution between
SW620 and Caco-2 cells, with strong accumulation in the nucleus
of Caco-2 cells. Fused to SQSTM1 it locates in cytoplasmic punc-
tuated structures representing both protein aggregates (green and
red), neutral autophagosomes (green and red) and acidiﬁed lyso-
somes (red only). Transient expression of the mCherry-EGFP-
SQSTM1 protein clearly demonstrated a higher number of red-only
structures in the Caco-2 cells compared to the SW620 cells (Fig. 6).
In addition, the frequency of cells with more acidic structures than
green structures was clearly higher in the Caco-2 cells. In response
to DHA there was an increase in the number of punctuated
structures that were both green and red in both cell lines. Based on
size, shape and ﬂuorescent color, many of these DHA-induced
structures with tagged SQSTM1 were most likely protein ag-
gregates. Altogether, these data show that DHA is not able to in-
duce autophagy in these two cell lines. However, in response to
DHA, there is an induction of endogenous SQSTM1 and formation
of protein aggregates positive for SQSTM1. Importantly, the basal
level of autophagy is higher in the Caco-2 cells compared to the
SW620 cells. Collectively, these results demonstrate an inverse
correlation between DHA sensitivity and basal autophagy in these
colon cancer cell lines.
3.4. NFE2L2-induced stress response is not the cause of DHA-sensi-
tivity in cancer cells
To investigate whether NFE2L2-induced stress responses are
important for the effect of DHA in cancer cells, siRNA targeting
NFE2L2 was used to knock down the protein in SW620 and Caco-2
cells. In both cell lines, DHA (70 and 140 mM) induces protein ex-
pression of NFE2L2 and SQSTM1 (Fig. 7A). Targeting NFE2L2 by
siRNA transfection reduced the induction of NFE2L2 by DHA (70
and 140 mM) in both cell lines (Fig. 7B). A reduction of SQSTM1 was
observed in both cell lines and the level of the autophagy bio-
marker LC3B-II in Caco-2 and SW620 control cells was increased
after NFE2L2 down regulation, suggesting a compensatory role of
increased autophagy (Fig. 7C). The increased level of LC3B-II was
not due to autophagy inhibition, since there was a clear further
increase in response to lysosomal inhibition by BafA1. Down reg-
ulation of NFE2L2 did not cause an increased sensitivity for DHA in
SW620 and Caco-2 cells (Fig. 7G). Also, siRNA-mediated down
regulation of SQSTM1 in Caco-2 cells did not cause increased
sensitivity towards DHA even if the down regulation was very
efﬁcient (data not shown). As previously mentioned, HMOX1 is
expressed in Caco-2 control cells in contrast to SW620 control
cells (Fig. 7D). However, siRNA-mediated down-regulation of
HMOX1 did not affect cell growth in either cell lines (Fig. 7G).
3.5. The level of autophagy is important for DHA-induced toxicity
To determine whether basal autophagic ﬂux was important for
the sensitivity towards DHA, ATG5 or a combination of ATG5 and
ATG7 was targeted by siRNA in Caco-2 cells (Fig. 7E/F). By com-
bining siRNA targeting both ATG5 and ATG7, a tenfold reduction of
the LC3B-II protein level was observed (Fig. 7E). Caco-2 cells
transfected with ATG5 and ATG7 siRNA demonstrated reduced cell
index compared to the non-targeting transfected cells in the
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Fig. 6. The localization pattern of mCherry-EGFP (CG) tagged SQSTM1 in Caco-2 and SW620 cells. Cells expressing the CG double tag alone or fused with SQSTM1 for 24 h
were left untreated or exposed to DHA (70 mM) for 16 h before ﬁxation and confocal imaging. The cells are representative for more than 300 single cells evaluated for each
condition. Scale bar 10 mm. (For interpretation of the references to color in this ﬁgure, the reader is referred to the web version of this article.)
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16 h. Results are based on triplicate experiments (7SD) for SW620 cells and for Caco-2 cells results from one representative experiment is shown. *Signiﬁcantly different
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siRNA in Caco-2 cells treated with BafA1 (100 nM) for 2 h. The level of the respective proteins in the NT cells was set to one and the level is indicated below each protein
band. (F) Relative changes in cell index of DHA-treated (140 μM) Caco-2 cells transfected with NT, ATG5 or a combination of ATG5 and ATG7 siRNA based on real-time
monitoring using the xCELLigence instrument. The cell index for the DHA-treated NT siRNA transfected cells were used for normalization. The relative differences in cell
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knock down cells were analyzed by conventional cell counting in
both SW620 and Caco-2 cells and was found to be increased in
both cell lines to almost the same extent (Fig. 7G). Importantly, in
the absence of DHA, the ATG5 or ATG7 siRNA transfected cells did
not grow slower than the control siRNA transfected cells. Con-
sistent with the hypothesis that basal autophagy is important for
survival during DHA exposure, increasing the autophagic ﬂux in
SW620 and Caco-2 cells, using rapamycin, reduced the DHA sen-
sitivity (Fig. 8A/B). In line with these ﬁndings, we show that by
inhibiting autophagy with chloroquine, an increased sensitivity
towards DHA is observed in Caco-2 cells (Fig. 8C). The protein
expression level of the autophagy markers LC3B-II and/or SQSTM1
respond accordingly (Fig. 8B/C).
Collectively, these results suggest that basal autophagy is im-
portant for the DHA-sensitivity in these cancer cells.4. Discussion
DHA was found to induce several autophagy-related transcripts
at early time points in SW620 colon cancer cells that are growth
inhibited by DHA; among these are SQSTM1 and BAG3 followed by
LC3B, GABARAPL1 and ULK1. However, in SW620 cells the induced
transcription of autophagy related genes did not result in a cor-
responding activation of autophagy, and we ﬁnd a low level of
autophagy both prior to and after DHA supplementation in these
cells. Caco-2 cells, with higher DHA-tolerance, display a much
higher basal autophagy, both in the presence and absence of DHA.
The lack of increased autophagic ﬂux in response to DHA inSW620 cells was surprising, because we have previously demon-
strated a clear activation of both ER stress [14] and ROS-accumu-
lation [12]; processes that are well documented to cause activation
of autophagy. Indicative of ER-stress, several downstream targets
of PERK like ATF4 and DNA damage-inducible protein 3 (DDIT3/
CHOP), were found to be induced in SW620 cells; both ATF4 and
CHOP may induce the expression of autophagy genes [14,35].
The increased expression of autophagy genes in the SW620
cells in response to DHA could be a sign of a transcriptionally
encoded response to counteract accumulation of damaged pro-
teins. The ﬁnding that these cancer cells do not increase the au-
tophagic ﬂux indicates that this transcriptional response is blocked
at a translational or post-translational stage. We have previously
found increased phosphorylation of eIF2α, indicative of ER-stress
and shut down of general translation, as early as 3 h after DHA
supplementation [14]. ER stress and release of calcium are also
known to induce autophagy [17]. The eIF2α/ATF4 pathway has
previously been shown to mediate gene transcriptional activation
of several autophagy genes in response to both amino acid star-
vation and ER-stress [36]. Further research is necessary to clarify
the mechanisms by which eIF2α phosphorylation regulates au-
tophagy in response to ER stress signals.
ROS may regulate autophagy both by transcriptional regulatory
mechanisms and post-translational modiﬁcations. Increased levels
of ROS-induced stress response activates hypoxia inducible factor
1 (HIF-1), p53, forkhead box O3 (FOXO3) and NFE2L2 which then
induce transcription of LC3B, BNIP3 and SQSTM1 [37]. Also,
downstream targets of the ER stress sensor PERK induce expres-
sion of autophagy genes (LC3 and ATG5) thereby increasing au-
tophagic ﬂux [37]. We ﬁnd that SQSTM1 (3 h), NFE2L2 (6 h) BNIP3
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in the SW620 cells, indicating that the transcriptional machinery
of autophagy is active in these cells.
ROS have also been suggested to induce autophagy by directly
controlling the enzymatic activity of ATG4 needed for maturation
of LC3-family members and formation of LC3B-II-positive autop-
hagosomes [18]. In addition, it was recently reported that ROS
cause an AMP-dependent activation of AMPK [38]. This kinase is
crucial for the control of autophagy. ULK1 is phosphorylated and
activated by AMPK [39], and AMPK also inhibits mTOR to increase
autophagic ﬂux [15]. DHA-induced transcription of several au-
tophagy-related genes may possibly act in concert with ROS-in-
duced activation of AMPK, thereby causing a posttranslational
activation of autophagy by increased ULK1 activity. In line with
this notion, Jing et al. recently demonstrated that DHA causes an
AMPK-dependent activation of autophagy in human cervical can-
cer SiHa cells [40]. This increased autophagy is suggested to con-
tribute to increased cytotoxicity in a wild type p53 dependent
manner. We ﬁnd however the difference in DHA-sensitivity to be
independent of wild type p53, since both Caco-2 and SW620 cells
lack wild-type p53 [41]. Amino acid starvation of SW620 cells
shows that autophagy is inducible in these cells. However, we still
do not know why there are no detectable activation of autophagy
in the SW620 cells after DHA-induced ROS and activation of au-
tophagy-related genes. Niso-Santano et al. recently published the
unexpected ﬁnding that unsaturated fatty acids promote autop-
hagy in a beclin 1- (BECN1) and phosphatidylinositol 3-kinase,
class 3-independent (PIK3C3) manner that is accompanied by the
redistribution of LC3B to Golgi-associated vesicles, thereby relying
on an intact Golgi apparatus [42]. This remains to be elucidated in
our systems.
A study by Shin et al. show that supplementation of prostate
cancer cell lines harboring mutant p53 with DHA results in gen-
eration of mitochondrial ROS and increased autophagic ﬂux, sug-
gesting that DHA induces both autophagy and apoptosis in these
cells [43]. In contrast to these results, we ﬁnd that both SW620
and Caco-2 cells harboring mutant p53 predicted to be damaging
or non-functional [41], do not increase autophagic ﬂux in response
to DHA. Why certain cancer cells are unable to accelerate autop-
hagy in response to stressful situations and how common this
feature is, is not known. However, mutations in the autophagy
gene Beclin1 are commonly found in cancers [44,45]. Furthermore,
negative regulators of autophagy, such as PI3K and AKT are es-
tablished oncogenes, and vice versa, positive regulators of the
process, such as PTEN and TSC1/TSC2 are tumor suppressors [16].
Mutations in these genes may contribute to an inability to accel-
erate autophagy upon exposure to stress. Whether this is the case
for SW620 or Caco-2 cells remains to be elucidated. Regardless, as
autophagy is not induced by DHA in either cell line, we ﬁnd that
the basal autophagy is a determinant as to whether the cells sur-
vive DHA exposure.
The three most commonly mutated oncogenes in colorectal
cancer cells are KRAS, BRAF and PI3KCA [46]. Caco-2 cells harbor no
mutations in these oncogenes, while SW620 cells harbor KRAS
mutation. The signaling pathways RAS/PKA and RAS/ERK have
been shown to be involved in the regulation of autophagy [47] and
many cancer cell lines harboring RAS mutations have also been
shown to have high levels of autophagy [48]. There is a strong
relationship between KRAS mutation and the NF-κB signaling
pathway. SW620 cells have a constitutive activation of NF-κB in
contrast to Caco-2 cells, and when treating both cell lines with a
NF-κB inhibitor, the proliferation of SW620 cells was signiﬁcantly
decreased while the proliferation of Caco-2 cells was unaffected
[49]. We have previously shown that DHA-treatment (70 mM) re-
duces total protein level of NF-κB in SW620 cells [35]. The role of
KRAS mutation and NF-κB signaling in the regulation of autophagyremains to be elucidated in our system.
SW620 cells demonstrate a robust production of ROS in re-
sponse to DHA at early time points, whereas a signiﬁcant increase
in ROS measured as MDA was detected in Caco-2 cells after sup-
plementation with DHA for 72 h. Vitamin E did not counteract
DHA-induced ROS as measured in our systems and did not inter-
fere with nuclear translocation of NFE2L2 in SW620 cells. Also,
vitamin E was not able to restore cell growth, indicating that lipid
peroxidation may not be the major cause of DHA-induced cyto-
toxicity in SW620 cells. In contrast, vitamin E was able to reduce
the level of MDA in Caco-2 cells, but not below that in control
cultures. Cancer cells may display differences in the antioxidant
defense systems or differences in the metabolic pathways for
PUFAs that may explain these observations. HMOX-1, well known
to be induced by a variety of stress stimuli, may contribute to the
cells antioxidant defense against stress induced by ROS and
thereby their sensitivity towards DHA. Therefore, it is interesting
that HMOX1 was expressed in Caco-2 control cells and not in the
DHA-sensitive SW620 control cells. However, knock-down of
HMOX1 did not affect DHA-sensitivity of either cell lines, in-
dicating that this is a more general stress indicator.
DHA has previously been found to induce ROS-dependent ag-
gregation and autophagic destruction of misfolded apolipoprotein
B in hepatocytes [50]. Our ﬁndings suggest that DHA induces
oxidative stress that may result in protein damage. The results
from the double tag experiments demonstrated increased levels of
protein aggregates positive for SQSTM1 in response to DHA. The
rapid production of ROS and activation of NFE2L2 suggest in-
creased ROS as an early response to PUFAs in SW620 cells. Sub-
sequently, this ROS increase could contribute to protein misfolding
and ER stress [51]. A close connection between these stress con-
ditions is also illustrated by the important role of NFE2L2 in cell
survival after ER stress [52]. However, it is difﬁcult to separate
these two intertwined stress conditions, and we have currently no
ﬁrm data that demonstrate which controls the other upon DHA
exposure.
Addition of DHA was found to cause a rapid stabilization and
nuclear translocation of NFE2L2 in both SW620 and Caco-2 cells.
In spite of this, we observed only a small increase (not signiﬁcant)
in ROS for the superoxide probe after prolonged exposure in the
Caco-2 cells. NFE2L2 activation is negatively regulated by KEAP1.
The cellular level of KEAP1 was recently shown to be controlled by
autophagy; SQSTM1 makes a direct interaction and targets KEAP1
for lysosomal destruction [31,32]. Thus, in cells with a high level of
SQSTM1 and autophagy, KEAP1 is rapidly degraded leading to
activation of NFE2L2. In line with this, we found the basal level of
KEAP1 to be lower in Caco-2 cells compared to SW620 cells. Im-
portantly, the afﬁnity of SQSTM1 for KEAP1 was recently shown to
be regulated by phosphorylation of SQSTM1 [53]. This phosphor-
ylation of SQSTM1 and the resulting activation of NFE2L2 were
found to be induced by diverse cellular stress conditions including
arsenate and mitochondrial inhibition and to be rapamycin sen-
sitive. As mentioned earlier, NFE2L2 is also regulated by phos-
phorylation by PERK after ER stress [28]. The stabilization and
nuclear translocation of NFE2L2 could therefore be mediated by
such an alternative mechanism in response to DHA.
Several age-related diseases are associated with elevated levels
of damaged mitochondria and protein aggregates [54,55]. Stimu-
lation of autophagy leads to reduced accumulation of such dys-
functional cellular components [56]. Autophagy acts pro-survival
by clearing cells for damaged components and may thereby mo-
bilize a disease preventive effect. This is in line with our ﬁndings
showing that stimulation or inhibition of autophagy by rapamycin
or chloroquine respectively, affects the DHA-induced toxicity in
our system. Our data suggest that in cancer cells where the au-
tophagy response may be defective or down regulated, DHA may
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The frequency of tumors composed of cancer cells with down-
regulated or loss of autophagy is currently not known. Un-
fortunately, there are currently limited possibilities to determine
the actual autophagic ﬂux in clinical samples of solid tumors, and
the understanding of the role of autophagy in cancer development
is still incomplete.
To test if the autophagic ﬂux is affected after DHA supple-
mentation in vivo, biomarkers that allow quantiﬁcation of autop-
hagy in clinical samples are needed. With such, we can evaluate if
and how the process might change in response to intake of n3
PUFAs in both normal and cancer cells. Development of diagnostic
tools of autophagy and autophagy regulators is also needed in
order to test the hypothesis that cancer cells with loss of autop-
hagy could be sensitive for DHA in clinical settings.Acknowledgments
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